BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20566540)

  • 1. Access to diabetes care and medicines in the Philippines.
    Higuchi M
    Asia Pac J Public Health; 2010 Jul; 22(3 Suppl):96S-102S. PubMed ID: 20566540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering diabetes care in the Philippines and Vietnam: policy and practice issues.
    Beran D; Higuchi M
    Asia Pac J Public Health; 2013 Jan; 25(1):92-101. PubMed ID: 21727084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Care in the Philippines.
    Tan GH
    Ann Glob Health; 2015; 81(6):863-9. PubMed ID: 27108153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
    Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
    Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
    Musich S; Wang S; Hawkins K
    Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Access and Affordability Working Group: Conclusions and Recommendations.
    Cefalu WT; Dawes DE; Gavlak G; Goldman D; Herman WH; Van Nuys K; Powers AC; Taylor SI; Yatvin AL;
    Diabetes Care; 2018 Jun; 41(6):1299-1311. PubMed ID: 29739814
    [No Abstract]   [Full Text] [Related]  

  • 7. Healthcare reform in diabetes: more ranting about a broken system.
    Hirsch IB
    Diabetes Technol Ther; 2013 Mar; 15(3):212-3. PubMed ID: 23458366
    [No Abstract]   [Full Text] [Related]  

  • 8. The Colombian health insurance system and its effect on access to health care.
    Alvarez LS; Salmon JW; Swartzman D
    Int J Health Serv; 2011; 41(2):355-70. PubMed ID: 21563628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Part D coverage gap and adherence to diabetes medications.
    Gu Q; Zeng F; Patel BV; Tripoli LC
    Am J Manag Care; 2010; 16(12):911-8. PubMed ID: 21348561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content, participants and outcomes of three diabetes care programmes in three low and middle income countries.
    Van Olmen J; Marie KG; Christian D; Clovis KJ; Emery B; Maurits VP; Heang H; Kristien VA; Natalie E; François S; Guy K
    Prim Care Diabetes; 2015 Jun; 9(3):196-202. PubMed ID: 25281167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pharmaceutical treatment of diabetes and family financial burdens.
    Sarpong EM; Bernard DM; Miller GE
    Med Care Res Rev; 2012 Aug; 69(4):474-91. PubMed ID: 22513449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The availability, price and affordability of antidiabetic drugs in Hubei province, China.
    Gong S; Cai H; Ding Y; Li W; Juan X; Peng J; Jin S
    Health Policy Plan; 2018 Oct; 33(8):937-947. PubMed ID: 30215707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the burden of health care financing and the distribution of health care benefits in Ghana, Tanzania and South Africa.
    Macha J; Harris B; Garshong B; Ataguba JE; Akazili J; Kuwawenaruwa A; Borghi J
    Health Policy Plan; 2012 Mar; 27 Suppl 1():i46-54. PubMed ID: 22388500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does increased adherence to medications change health care financial burdens for adults with diabetes?
    Miller GE; Sarpong EM; Hill SC
    J Diabetes; 2015 Nov; 7(6):872-80. PubMed ID: 25817601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.
    McGuire H; Kissimova-Skarbek K; Whiting D; Ji L
    Diabetes Res Clin Pract; 2011 Nov; 94(2):307-10. PubMed ID: 22056720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "It is the medicines that keep us alive": lived experiences of diabetes medication use and continuity among adults in Southeastern Tanzania.
    Metta E; Haisma H; Kessy F; Geubbels E; Hutter I; Bailey A
    BMC Health Serv Res; 2015 Mar; 15():111. PubMed ID: 25890162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to diabetes care and treatment in Africa : challenges and opportunities.
    Beran D; Besançon S
    Med Sante Trop; 2018 Nov; 28(4):351-354. PubMed ID: 30799816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitudes and perceptions of people with type 2 diabetes as related to self-management practices: Results of a cross-sectional study conducted in Luzon, Philippines.
    Ku GM; Kegels G
    Chronic Illn; 2015 Jun; 11(2):93-107. PubMed ID: 24907237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of Type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru.
    Cardenas MK; Miranda JJ; Beran D
    Diabet Med; 2016 Jun; 33(6):752-60. PubMed ID: 27194174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.
    Beran D; Ewen M; Lipska K; Hirsch IB; Yudkin JS
    Curr Diab Rep; 2018 Jun; 18(8):48. PubMed ID: 29907884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.